Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Altrazeal Life Sciences Inc.Listing unverified | BuyD (derivative) | $5M | First in 12mo | SEC | |
Altrazeal Life Sciences Inc.Listing unverified | Buy | n/a (No price was disclosed in the filing) | conv 38First in 12mo | SEC | |
Altrazeal Life Sciences Inc.Listing unverified | BuyD (derivative) | n/a (No price was disclosed in the filing) | First in 12mo | SEC | |
Altrazeal Life Sciences Inc.Listing unverified | BuyD (derivative) | $250B | First in 12mo | SEC |